Therapeutic use of a growth factor, METRNL
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Dec 18, 2012
Issued Date -
N/A
app pub date -
Jul 7, 2009
filing date -
Jul 24, 2008
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The present invention relates to the field of therapeutic use of proteins, genes and cells, in particular to the therapy based on the biological function of a secreted therapeutic protein, METRNL, in particular for the treatment of disorders of the nervous system. METRNL is a Nerve Survival and Growth factor with neuroprotective and/or neurogenesis effects.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully